Financhill
Back

Aura Biosciences Quote, Financials, Valuation and Earnings

Aura Biosciences Price Quote

$8.44
+0.03 (+0%)
(Updated: December 14, 2024 at 5:24 AM ET)

Aura Biosciences Key Stats

Sell
5
Aura Biosciences (AURA) is a Sell

Day range:
$8.32 - $8.51
52-week range:
$6.63 - $12.38
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.41%

Volume:
121.5K
Avg. volume:
207.1K
1-year change:
-3%
Market cap:
$420.1M
Revenue:
$0
EPS:
$-1.73

How Much Does Aura Biosciences Make?

Data Unavailable

Is Aura Biosciences Growing As A Company?

Data Unavailable

Aura Biosciences Stock Price Performance

  • Did Aura Biosciences Stock Go Up Last Month?
    Aura Biosciences share price went down by -18.59% last month
  • Did AURA's Share Price Rise Over The Last Year?
    AURA share price fell by -3% over the past 1 year

What Is Aura Biosciences 52-Week High & Low?

Aura Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aura Biosciences?

  • How Much Debt Does Aura Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Aura Biosciences Have?
    Cash and short term investments quarterly total is $174.4M
  • What Is Aura Biosciences’s Book Value Per Share?
    Book value per share is 3.51

Is Aura Biosciences Cash Flow Positive?

  • What Is AURA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$73.2M
  • What Is Aura Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $94M
  • What Is Aura Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$51M

Aura Biosciences Return On Invested Capital

Data Unavailable

Aura Biosciences Earnings Date & Stock Price

Aura Biosciences Competitors

  • Who Are Aura Biosciences's Competitors?
    Below is a list of companies who compete with Aura Biosciences or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Aura Biosciences Dividend Yield

Aura Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 22.14
Upside from Last Price: 163.29%

Major Shareholders

  • How many AURA shares are owned by institutional investors?
    51M AURA shares are owned by institutional investors
  • How many AURA shares are owned by insiders?
    1.2M AURA shares are owned by insiders